| Judy E Borland, MD | |
|
915 4th St. Nw, Choteau, MT 59422 | |
| (406) 466-5763 | |
| (406) 466-2159 |
| Full Name | Judy E Borland |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 46 Years |
| Location | 915 4th St. Nw, Choteau, Montana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871556613 | NPI | - | NPPES |
| 560356972 | Other | AR | MEDICARELINKED |
| 102102001 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 4884 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Benefis Teton Medical Center | Choteau, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Benefis Community Hospitals Inc | 9931414950 | 9 |
News Archive
New research appearing in the journal Scientific Reports unpacks the list of chemicals that comprise flavored e-liquids and pods used in vaping and details their harmful effects to lung tissue, including inflammation and genetic damage that could indicate long-term risk for respiratory disease and even cancer.
Onconome, Inc. announced today that it was awarded a cash grant totaling approximately $231,000 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program. The QTDP was enacted as part of the Patient Protection and Affordable Care Act of 2010.
Patients who survive a cerebral hemorrhage may suffer delayed severe brain damage caused by free hemoglobin, which comes from red blood cells and damages neurons. Researchers at the University of Zurich and the UniversityHospital Zurich have now discovered a protective protein in the body called haptoglobin, which prevents this effect.
A recent study, affiliated with UNIST has proposed the possibility of in situ human health monitoring simply by wearing a contact lens with built-in wireless smart sensors.
› Verified 5 days ago
| Entity Name | Benefis Community Hospitals Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083602205 PECOS PAC ID: 9931414950 Enrollment ID: O20160525000652 |
News Archive
New research appearing in the journal Scientific Reports unpacks the list of chemicals that comprise flavored e-liquids and pods used in vaping and details their harmful effects to lung tissue, including inflammation and genetic damage that could indicate long-term risk for respiratory disease and even cancer.
Onconome, Inc. announced today that it was awarded a cash grant totaling approximately $231,000 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program. The QTDP was enacted as part of the Patient Protection and Affordable Care Act of 2010.
Patients who survive a cerebral hemorrhage may suffer delayed severe brain damage caused by free hemoglobin, which comes from red blood cells and damages neurons. Researchers at the University of Zurich and the UniversityHospital Zurich have now discovered a protective protein in the body called haptoglobin, which prevents this effect.
A recent study, affiliated with UNIST has proposed the possibility of in situ human health monitoring simply by wearing a contact lens with built-in wireless smart sensors.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Judy E Borland, MD 915 4th St. Nw, Choteau, MT 59422 Ph: (406) 466-6085 | Judy E Borland, MD 915 4th St. Nw, Choteau, MT 59422 Ph: (406) 466-5763 |
News Archive
New research appearing in the journal Scientific Reports unpacks the list of chemicals that comprise flavored e-liquids and pods used in vaping and details their harmful effects to lung tissue, including inflammation and genetic damage that could indicate long-term risk for respiratory disease and even cancer.
Onconome, Inc. announced today that it was awarded a cash grant totaling approximately $231,000 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program. The QTDP was enacted as part of the Patient Protection and Affordable Care Act of 2010.
Patients who survive a cerebral hemorrhage may suffer delayed severe brain damage caused by free hemoglobin, which comes from red blood cells and damages neurons. Researchers at the University of Zurich and the UniversityHospital Zurich have now discovered a protective protein in the body called haptoglobin, which prevents this effect.
A recent study, affiliated with UNIST has proposed the possibility of in situ human health monitoring simply by wearing a contact lens with built-in wireless smart sensors.
› Verified 5 days ago